JPRN-UMIN000025429已完成未知
Post-marketing surveillance for acute Kawasaki Disease under Remicade treatment - SAKURA study
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 291
研究概览
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 15years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with acute Kawasaki disease who meet "CONTRAINDICATIONS" to the use of the Drug
研究者
相似试验
已完成
不适用
A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New DrugsHepatitis C Virus (HCV)NCT03201718AbbVie505
已完成
不适用
Prevenar13 Post Market SurveillanceHealthyNCT01509105Pfizer649
已完成
不适用
Lyrica (Pregabalin) Korean Post Marketing Surveillance StudyNeuropathic PainPost-market SurveillanceEpilepsyFibromyalgiaNCT01220180Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4,175
招募中
不适用
A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19COVID-19NCT05890612Pfizer3,000
已完成
不适用
Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry StudySafety SurveillanceAdverse Drug EventsAdverse Drug ReactionsSevere Adverse EventsSevere Adverse ReactionsNCT02239237Zhong Wang30,283